Endoron Medical

Endoron Medical is a medical device company developing endovascular anchoring solutions to improve outcomes for patients undergoing aortic repair procedures. Its flagship products — Aortoseal, an endostapling system for EVAR that mimics surgical suturing to prevent graft migration and endoleaks, and Aortodock, a transcatheter valve docking solution for calcium- and leaflet-independent anchoring — extend across the full aortic continuum from EVAR to TEVAR and structural heart. Endoron's customers are vascular and cardiac surgeons seeking more durable, predictable alternatives to current EVAR fixation methods. The company is backed by Sofinnova Partners and the European Innovation Council and has received FDA IDE approval for its SEAL360 pivotal study.